| Literature DB >> 10861195 |
A Pratelli1, A Cavalli, G Normanno, M G De Palma, G Pastorelli, V Martella, C Buonavoglia.
Abstract
The results of vaccination trials carried out on pups with maternally derived antibodies (MDA) to canine parvovirus (CPV), using a modified-live CPV-2b variant vaccine (29-97/40 strain), are reported. The vaccine was able to overcome the obstacle of MDA, and to elicit protective immunity in 100% of the pups whose antibody titres were 1:10-1:40, 83% of the pups with titres of 1:80, 57% of the pups with titres of 1:160, and even in 60% of the pups with antibody titres of 1:320.Entities:
Mesh：
Substances：
Year: 2000 PMID： 10861195 DOI： 10.1046/j.1439-0450.2000.00340.x
Source DB: PubMed Journal: J Vet Med B Infect Dis Vet Public Health ISSN： 0931-1793